Related references
Note: Only part of the references are listed.Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood
Ilaria Vicenti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection
Irini Sereti et al.
CLINICAL INFECTIOUS DISEASES (2017)
Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
Nina N. Hosmane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir
Thor A. Wagner et al.
AIDS RESEARCH AND THERAPY (2017)
HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults
Philippa C. Matthews et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
HIV-specific CD8+ T cells and HIV eradication
R. Brad Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dysfunctional phenotypes of CD4+and CD8+T cells are comparable in patients initiating ART during early or chronic HIV-1 infection
Sylvie Amu et al.
MEDICINE (2016)
HIV-1 Eracication: Early Trials (and Tribulations)
Adam M. Spivak et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth (vol 12, e1005472, 2016)
Maja Kiselinova et al.
PLOS ONE (2016)
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report
Pierre Frange et al.
LANCET HIV (2016)
Combined eff ect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth et al.
LANCET HIV (2016)
Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
Heloise M. Delagreverie et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants
Margaret McManus et al.
PLOS ONE (2016)
Paediatric HIV infection: the potential for cure
Philip J. Goulder et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061
Bret J. Rudy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Towards an HIV-1 cure: measuring the latent reservoir
Katherine M. Bruner et al.
TRENDS IN MICROBIOLOGY (2015)
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst et al.
NATURE COMMUNICATIONS (2015)
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian H. Elliott et al.
LANCET HIV (2015)
Induced immunity against hepatitis B virus
Zeinab Nabil Ahmed Said et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy
Guillaume J. Besson et al.
CLINICAL INFECTIOUS DISEASES (2014)
HIV-1 persistence in CD4+ T cells with stem cell like properties
Maria J. Buzon et al.
NATURE MEDICINE (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial
Mark F. Cotton et al.
LANCET (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Virus Inhibition Activity of Effector Memory CD8+ T Cells Determines Simian Immunodeficiency Virus Load in Vaccinated Monkeys after Vaccine Breakthrough Infection
Takuya Yamamoto et al.
JOURNAL OF VIROLOGY (2012)
Inhibitory Potential of Subpopulations of CD8+ T Cells in HIV-1-Infected Elite Suppressors
Robert W. Buckheit et al.
JOURNAL OF VIROLOGY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection
HM Rosenblatt et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load
SG Deeks et al.
BLOOD (2004)
Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children
S Resino et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2003)
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
HF Günthard et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
